By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Gamida Cell Ltd. 

Harey Yehuda 54
P.O.B. 94
Savyon    56530  Israel
Phone: 03-534-7482 Fax: 03-534-3067



Company News
Gamida Cell Announces First Patient Transplanted In Phase I/II Study Of CordIn For Severe Aplastic Anemia And Hypoplastic MDS 8/21/2017 6:55:21 AM
Gamida Cell Announces $3.5 Million Grant From The Israeli Government 7/20/2017 6:49:14 AM
Gamida Cell Names Ronit Simantov, M.D. As Chief Medical Officer 7/10/2017 7:30:12 AM
Israel's Gamida Cell Banks $40 Million For Bone Marrow Trial 6/19/2017 6:03:10 AM
Gamida Cell Appoints Nobel Prize Laureate Professor Roger Kornberg And Immune Oncology Expert Dr. Michael Perry To Its Board Of Directors 6/5/2017 11:27:57 AM
Gamida Cell Announces Publication Of Positive Clinical Outcomes From NiCord-Transplanted Patients In The Journal Of Biology Of Blood And Marrow Transplantation 4/20/2017 7:56:09 AM
Gamida Cell Receives Additional EMA Orphan Drug Designation For Nicord In Haematopoietic Stem Cell Transplantation (HSCT) 3/23/2017 7:00:49 AM
Gamida Cell Announces First Patient Transplanted In Phase III Registration Study Of Nicord For Blood Cancers 2/28/2017 6:21:05 AM
Gamida Cell Presents Positive Data From Phase 1/2 Study Of NiCord as A Curative Treatment For Sickle Cell Disease At American Society of Hematology 2016 12/6/2016 12:12:55 PM
Gamida Cell Names Julian Adams, Ph.D. New Chairman Of The Board 11/21/2016 11:16:47 AM